Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2003 1
2004 2
2005 2
2007 2
2010 2
2011 1
2014 1
2017 1
2018 1
2020 1
2021 5
2022 4
2023 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Colon cancer.
Labianca R, Beretta GD, Kildani B, Milesi L, Merlin F, Mosconi S, Pessi MA, Prochilo T, Quadri A, Gatta G, de Braud F, Wils J. Labianca R, et al. Among authors: milesi l. Crit Rev Oncol Hematol. 2010 May;74(2):106-33. doi: 10.1016/j.critrevonc.2010.01.010. Crit Rev Oncol Hematol. 2010. PMID: 20138539 Review.
Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial.
Siefker-Radtke AO, Matsubara N, Park SH, Huddart RA, Burgess EF, Özgüroğlu M, Valderrama BP, Laguerre B, Basso U, Triantos S, Akapame S, Kean Y, Deprince K, Mukhopadhyay S, Loriot Y; THOR cohort 2 investigators. Siefker-Radtke AO, et al. Ann Oncol. 2024 Jan;35(1):107-117. doi: 10.1016/j.annonc.2023.10.003. Epub 2023 Oct 21. Ann Oncol. 2024. PMID: 37871702 Clinical Trial.
Colorectal cancer: screening.
Labianca R, Beretta GD, Mosconi S, Milesi L, Pessi MA. Labianca R, et al. Among authors: milesi l. Ann Oncol. 2005;16 Suppl 2:ii127-32. doi: 10.1093/annonc/mdi730. Ann Oncol. 2005. PMID: 15958442 Free article. Review. No abstract available.
The development of clinical research in CRC.
Labianca R, Beretta GD, Mosconi S, Pessi MA, Milesi L. Labianca R, et al. Among authors: milesi l. Ann Oncol. 2005 May;16 Suppl 4:iv37-43. doi: 10.1093/annonc/mdi906. Ann Oncol. 2005. PMID: 15923427 Free article. Review. No abstract available.
Adjuvant treatment of colorectal cancer.
Beretta GD, Milesi L, Pessi MA, Mosconi S, Labianca R. Beretta GD, et al. Among authors: milesi l. Surg Oncol. 2004 Aug-Nov;13(2-3):63-73. doi: 10.1016/j.suronc.2004.09.008. Surg Oncol. 2004. PMID: 15572088 Review.
Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a post-hoc analysis.
Palmerini E, Sanfilippo R, Grignani G, Buonadonna A, Romanini A, Badalamenti G, Ferraresi V, Vincenzi B, Comandone A, Pizzolorusso A, Brunello A, Gelsomino F, De Pas T, Ibrahim T, Gurrieri L, Grosso F, Zanelli F, Pantaleo MA, Milesi L, Ciuffreda L, Ferrari V, Marchesi E, Quattrini I, Righi A, Setola E, Carretta E, Casali PG, Picci P, Ferrari S. Palmerini E, et al. Among authors: milesi l. Front Oncol. 2022 Dec 8;12:1042479. doi: 10.3389/fonc.2022.1042479. eCollection 2022. Front Oncol. 2022. PMID: 36568164 Free PMC article.
Recurrent retroperitoneal solitary fibrous tumor: a case report.
Manica M, Roscigno M, Naspro R, Sodano M, Milesi L, Gianatti A, Da Pozzo LF. Manica M, et al. Among authors: milesi l. Tumori. 2021 Dec;107(6):NP11-NP14. doi: 10.1177/0300891620974763. Epub 2020 Nov 25. Tumori. 2021. PMID: 33238803
The role of adjuvant chemotherapy in colon cancer.
Labianca R, Milesi L, Mosconi S, Pessi MA, Beretta GD, Quadri A. Labianca R, et al. Among authors: milesi l. Surg Oncol. 2007 Dec;16 Suppl 1:S93-6. doi: 10.1016/j.suronc.2007.10.042. Surg Oncol. 2007. PMID: 18257148 Review.
23 results